{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:38:25Z","timestamp":1789763905428,"version":"4.0.1"},"reference-count":163,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.tcm.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T08:16:21Z","timestamp":1537431381000},"page":"285-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Amiodarone and thyroid physiology, pathophysiology, diagnosis and management"],"prefix":"10.1016","volume":"29","author":[{"given":"Richard G.","family":"Trohman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parikshit S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"McAninch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.tcm.2018.09.005_bib0001","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","article-title":"Prescribing amiodarone: an evidence-based review of clinical indications","volume":"298","author":"Vassallo","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/FJC.0b013e31818914b6","article-title":"Amiodarone as paradigm for developing new drugs for atrial fibrillation","volume":"52","author":"Singh","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4 Pt 2","key":"10.1016\/j.tcm.2018.09.005_bib0003","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0002-8703(83)90022-4","article-title":"Ten years of experience with amiodarone","volume":"106","author":"Rosenbaum","year":"1983","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0004","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0002-9149(76)90807-9","article-title":"Clinical efficacy of amiodarone as an antiarrhythmic agent","volume":"38","author":"Rosenbaum","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2018.09.005_bib0005","unstructured":"Fogoros RN. The Strange History of Amiodarone. Available at https:\/\/www.verywellhealth.com\/the-strange-history-of-amiodarone-1745987 Last accessed 8\/9\/18."},{"issue":"Oct (4)","key":"10.1016\/j.tcm.2018.09.005_bib0006","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0735-1097(85)80489-7","article-title":"Amiodarone and the American Way","volume":"6","author":"Winkle","year":"1985","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0007","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1540-8159.1998.tb00218.x","article-title":"Evolution and revolution in drug labeling: regulation of antiarrhythmic drugs by the Food and Drug Administration 1962\u20131996","volume":"21","author":"Pritchett","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"issue":"12","key":"10.1016\/j.tcm.2018.09.005_bib0008","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199909163411203","article-title":"Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation","volume":"341","author":"Kudenchuk","year":"1999","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.tcm.2018.09.005_bib0009","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","article-title":"Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation","volume":"346","author":"Dorian","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.CIR.102.7.742","article-title":"Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy","volume":"102","author":"Nademanee","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.09.005_bib0011","first-page":"1329","article-title":"Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study","volume":"38","author":"Ortiz","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2018.09.005_bib0012","author":"Al-Khatib","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.tcm.2018.09.005_bib0013","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-122-10-199505150-00007","article-title":"Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist","volume":"122","author":"Pinski","year":"1995","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.tcm.2018.09.005_bib0014","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.hrthm.2012.09.002","article-title":"There are lots of things about implantable cardioverter-defibrillators that should be eliminated: shocks are a good start","volume":"9","author":"Sweeney","year":"2012","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.hrthm.2009.11.027","article-title":"Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients","volume":"7","author":"Sweeney","year":"2010","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0016","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.amjcard.2013.09.023","article-title":"Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR])","volume":"113","author":"Dev","year":"2014","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0017","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.111.019927","article-title":"Antiarrhythmic drug therapy for atrial fibrillation","volume":"125","author":"Zimetbaum","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.7326\/0003-4819-143-5-200509060-00008","article-title":"Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis","volume":"143","author":"Aasbo","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tcm.2018.09.005_bib0019","unstructured":"Kumar K, Zimetbaum PJ. Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: clinical trials. Available at: https:\/\/www.uptodate.com\/contents\/antiarrhythmic-drugs-to-maintain-sinus-rhythm-in-patients-with-atrial-fibrillation-clinical-trials?topicRef=1033&source=see_link Last accessed 8\/9\/18."},{"issue":"Apr (17)","key":"10.1016\/j.tcm.2018.09.005_bib0020","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9149(02)03008-4","article-title":"Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000","volume":"91","author":"Al-Khatib","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2018.09.005_bib0022","unstructured":"Cordarone\u00ae (amiodarone HCl) TABLETS. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/018972s044lbl.pdf Last accessed 8\/8\/18."},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0023","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.tcm.2018.09.005_bib0024","author":"Gopalan"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7326\/0003-4819-126-1-199701010-00009","article-title":"Effects of amiodarone on thyroid function","volume":"126","author":"Harjai","year":"1997","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0735-1097(87)80098-0","article-title":"Thyroid dysfunction during chronic amiodarone therapy","volume":"9","author":"Albert","year":"1987","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0027","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0028","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","article-title":"Adverse effects of low dose amiodarone: a meta-analysis","volume":"30","author":"Vorperian","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.09.005_bib0029","series-title":"Electropharmacological control of cardiac arrhythmias","author":"Singh","year":"1994"},{"key":"10.1016\/j.tcm.2018.09.005_bib0030","series-title":"Braunwald's heart disease: a textbook of cardiovascular medicine","author":"Bonow","year":"2011"},{"issue":"Suppl1","key":"10.1016\/j.tcm.2018.09.005_bib0031","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1111\/j.1365-2125.2001.00768.x","article-title":"Therapeutic drug monitoring: antiarrhythmic drugs","volume":"52","author":"Campbell","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.tcm.2018.09.005_bib0032","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/archinte.160.12.1741","article-title":"Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology","volume":"160","author":"Goldschlager","year":"2000","journal-title":"Arch Intern Med"},{"issue":"Mar (3)","key":"10.1016\/j.tcm.2018.09.005_bib0033","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2125.2000.00134.x","article-title":"Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions","volume":"49","author":"Ohyama","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"Feb (4)","key":"10.1016\/j.tcm.2018.09.005_bib0034","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0928-0987(00)00215-3","article-title":"Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport","volume":"12","author":"Katoh","year":"2001","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.tcm.2018.09.005_bib0036","unstructured":"Ross DS. Amiodarone and thyroid dysfunction. Available at: https:\/\/www.uptodate.com\/contents\/amiodarone-and-thyroid-dysfunction Last accessed 8\/8\/18."},{"issue":"8","key":"10.1016\/j.tcm.2018.09.005_bib0037","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/thy.2005.15.835","article-title":"Regulation of type 1 iodothyronine deiodinase in health and disease","volume":"15","author":"Koenig","year":"2005","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0038","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1210\/me.2007-0490","article-title":"The thyroid hormone-inactivating deiodinase functions as a homodimer","volume":"22","author":"Sagar","year":"2008","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","article-title":"Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases","volume":"23","author":"Bianco","year":"2002","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0040","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1210\/er.2008-0019","article-title":"Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling","volume":"29","author":"Gereben","year":"2008","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0041","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/endo-115-4-1605","article-title":"Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes","volume":"115","author":"Aanderud","year":"1984","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0042","first-page":"193","article-title":"Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone","volume":"111","author":"Hershman","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0043","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/00005344-198912000-00006","article-title":"Rat heart thyroxine 5\u2032-deiodinase is sensitively depressed by amiodarone","volume":"14","author":"Gotzsche","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0044","first-page":"29","article-title":"Effect of amiodarone on the conversion of thyroxine to triiodothyronine in the myocardium of rats in vivo and in vitro","volume":"48","author":"Ceppi","year":"1988","journal-title":"Medicina (B Aires)"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI109143","article-title":"The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver","volume":"62","author":"Balsam","year":"1978","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0046","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1210\/endo-113-4-1464","article-title":"The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5\u2032-monodeiodination in rats","volume":"113","author":"Sogol","year":"1983","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0047","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2007-1012245","article-title":"Amiodarone inhibits T4 to T3 conversion and alpha-glycerophosphate dehydrogenase and malic enzyme levels in rat liver","volume":"18","author":"Pekary","year":"1986","journal-title":"Horm Metab Res"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0048","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/joe.0.1210431","article-title":"Effects of amiodarone on 5\u2032-deiodination of thyroxine to tri- iodothyronine in rat myocardium","volume":"121","author":"Ceppi","year":"1989","journal-title":"J Endocrinol"},{"issue":"11-12","key":"10.1016\/j.tcm.2018.09.005_bib0049","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s002280050701","article-title":"Structure-effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination","volume":"55","author":"Ha","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0014-5793(94)80245-9","article-title":"Amiodarone-induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA","volume":"341","author":"Hudig","year":"1994","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0051","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1210\/jcem-66-4-815","article-title":"Human epidermal keratinocytes in culture convert thyroxine to 3,5,3\u2032-triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin","volume":"66","author":"Kaplan","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tcm.2018.09.005_bib0052","first-page":"79","article-title":"Conversion of thyroxine to triiodothyronine in the anterior pituitary gland and the influence of this process on thyroid status","volume":"14","author":"Kaplan","year":"1984","journal-title":"Horm Metab Res Suppl"},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0053","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1210\/en.2005-1300","article-title":"Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism","volume":"147","author":"Christoffolete","year":"2006","journal-title":"Endocrinology"},{"issue":"2-3","key":"10.1016\/j.tcm.2018.09.005_bib0054","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yfrne.2007.04.002","article-title":"Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase","volume":"28","author":"Fekete","year":"2007","journal-title":"Front Neuroendocrinol"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cen.12538","article-title":"Defending plasma T3 is a biological priority","volume":"81","author":"Abdalla","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0056","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI108466","article-title":"Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones","volume":"58","author":"Burger","year":"1976","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0057","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1210\/jcem-53-5-997","article-title":"Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration","volume":"53","author":"Melmed","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0058","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/01.CIR.66.1.202","article-title":"Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy","volume":"66","author":"Nademanee","year":"1982","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.tcm.2018.09.005_bib0059","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1210\/mend.15.12.0740","article-title":"Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4","volume":"15","author":"Schneider","year":"2001","journal-title":"Mol Endocrinol"},{"issue":"2-3","key":"10.1016\/j.tcm.2018.09.005_bib0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejphar.2007.09.039","article-title":"Long-term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile","volume":"578","author":"Shi","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0061","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-5793(82)80900-9","article-title":"Decreased transport of thyroxine (T4), 3,3\u2032,5-triiodothyronine (T3) and 3,3\u2032,5\u2032-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs","volume":"140","author":"Krenning","year":"1982","journal-title":"FEBS Lett"},{"key":"10.1016\/j.tcm.2018.09.005_bib0062","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/endo.134.4.8137729","article-title":"Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein","volume":"134","author":"Bakker","year":"1994","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0063","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0303-7207(95)03578-U","article-title":"Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone alpha 1-receptor protein","volume":"112","author":"van Beeren","year":"1995","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0064","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/eje.0.1450059","article-title":"Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level","volume":"145","author":"Bogazzi","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/endo.142.1.7907","article-title":"Type 2 iodothyronine deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis","volume":"142","author":"Pachucki","year":"2001","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0066","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1210\/me.2003-0125","article-title":"Chronic cardiac-specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness","volume":"18","author":"Carvalho-Bianco","year":"2004","journal-title":"Mol Endocrinol"},{"issue":"15","key":"10.1016\/j.tcm.2018.09.005_bib0067","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1073\/pnas.0601072103","article-title":"Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction","volume":"103","author":"Trivieri","year":"2006","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0068","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1210\/jc.2002-022013","article-title":"Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients","volume":"88","author":"Peeters","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0069","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/me.2011-1325","article-title":"Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice","volume":"26","author":"Ueta","year":"2012","journal-title":"Mol Endocrinol"},{"issue":"10","key":"10.1016\/j.tcm.2018.09.005_bib0070","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1210\/en.2007-0043","article-title":"Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study","volume":"148","author":"Olivares","year":"2007","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0071","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1210\/endo.143.7.8985","article-title":"Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure","volume":"143","author":"Wassen","year":"2002","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0072","first-page":"975","article-title":"Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats","volume":"118","author":"Simonides","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tcm.2018.09.005_bib0073","doi-asserted-by":"crossref","DOI":"10.1210\/en.2012-2261","article-title":"Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice","author":"Hong","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.tcm.2018.09.005_bib0074","unstructured":"Tracy CM. Tachycardia-mediated cardiomyopathy. 8\/7\/2015 cited; Available from: http:\/\/www.uptodate.com\/contents\/tachycardia-mediated-cardiomyopathy."},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure","volume":"333","author":"Singh","year":"1995","journal-title":"New Engl J Med"},{"issue":"24","key":"10.1016\/j.tcm.2018.09.005_bib0076","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1016\/0006-2952(89)90648-5","article-title":"Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes","volume":"38","author":"Beddows","year":"1989","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0077","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1370089","article-title":"Amiodarone induces a different pattern of ultrastructural change in the thyroid to iodine excess alone in both the BB\/W rat and the Wistar rat","volume":"137","author":"Pitsiavas","year":"1997","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0078","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/eje.0.1370015","article-title":"Towards an animal model of amiodarone-induced thyroid dysfunction","volume":"137","author":"Wiersinga","year":"1997","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0079","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/jc.2014-2745","article-title":"Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis","volume":"100","author":"Lombardi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0080","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/endo-127-6-2930","article-title":"Amiodarone effects on thyrotropin receptors and responses stimulated by thyrotropin and carbachol in cultured dog thyroid cells","volume":"127","author":"Rani","year":"1990","journal-title":"Endocrinology"},{"issue":"Mar (3)","key":"10.1016\/j.tcm.2018.09.005_bib0081","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archinte.1984.00350150071023","article-title":"Clinical and chemical assessment of thyroid function during therapy with amiodarone","volume":"144","author":"Amico","year":"1984","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0082","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"91","author":"Trip","year":"1991","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0083","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-103-1-157_2","article-title":"Amiodarone and antithyroid antibodies","volume":"103","author":"Foresti","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tcm.2018.09.005_bib0084","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-62-4-714","article-title":"An autoregulatory effect of iodide in diverse thyroid disorders","volume":"62","author":"Selenkow","year":"1965","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0086","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/105072501300176462","article-title":"Iodine-Induced hypothyroidism","volume":"11","author":"Markou","year":"2001","journal-title":"Thyroid"},{"issue":"Jun (3)","key":"10.1016\/j.tcm.2018.09.005_bib0087","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2042018811398516","article-title":"Management of amiodarone-related thyroid problems","volume":"2","author":"Narayana","year":"2011","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"Jan (1)","key":"10.1016\/j.tcm.2018.09.005_bib0088","article-title":"The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran thyroid study","volume":"12","author":"Amouzegar","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0089","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2003.257","article-title":"Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations","volume":"48","author":"Ai","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0033-0620(89)90017-0","article-title":"Amiodarone and thyroid function","volume":"31","author":"Nademanee","year":"1989","journal-title":"Progr Cardiovasc Dis"},{"key":"10.1016\/j.tcm.2018.09.005_bib0091","first-page":"269","article-title":"Amiodarone-induced thyroid dysfunction in clinical practice","volume":"10","author":"Ursella","year":"2005","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0092","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0002-9343(78)90057-8","article-title":"Why does anyone still use desiccated thyroid USP?","volume":"64","author":"Jackson","year":"1978","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0093","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.beem.2009.06.002","article-title":"Lithium and thyroid","volume":"23","author":"Lazarus","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.tcm.2018.09.005_bib0094","unstructured":"Surks MI. Lithium and the thyroid. Available at: https:\/\/www.uptodate.com\/contents\/lithium-and-the-thyroid Last accessed 8\/13\/18."},{"key":"10.1016\/j.tcm.2018.09.005_bib0095","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202338","article-title":"Amiodarone-induced myxoedema coma","volume":"2014","author":"Hassan","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0096","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.5114\/aoms.2013.35026","article-title":"Amiodarone-induced myxedema coma - a case and review of the literature","volume":"10","author":"Chakraborty","year":"2014","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0097","first-page":"65","article-title":"Treatment of myxoedema coma\u2013factors associated with fatal outcome","volume":"108","author":"Hylander","year":"1985","journal-title":"Acta Endocrinol"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0098","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/cc6211","article-title":"Predictors of outcome in myxoedema coma: a study from a tertiary care centre","volume":"12","author":"Dutta","year":"2008","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0099","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/cc6218","article-title":"Predictors of outcome in myxoedema coma","volume":"12","author":"Beynon","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.tcm.2018.09.005_bib0100","unstructured":"Ross DS. Myxedema coma. 5\/31\/2015 [cited; Available from: http:\/\/www.uptodate.com\/contents\/myxedema-coma Last accessed 8\/13\/18."},{"issue":"11","key":"10.1016\/j.tcm.2018.09.005_bib0101","first-page":"814","article-title":"Autoregulation of the thyroid. Response to iodide excess and depletion","volume":"47","author":"Ingbar","year":"1972","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0102","first-page":"582","article-title":"Thyroid iodine content measured by x-ray fluorescence in amiodarone-induced thyrotoxicosis: concise communication","volume":"24","author":"Leger","year":"1983","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/jcem.86.1.7119","article-title":"Amiodarone-induced thyrotoxicosis","volume":"86","author":"Daniels","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1445-5994.1988.tb02237.x","article-title":"Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate","volume":"18","author":"Newnham","year":"1988","journal-title":"Aust N Z J Med"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0105","first-page":"421","article-title":"Amiodarone-induced thyrotoxicosis: a review","volume":"25","author":"Tsang","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.tcm.2018.09.005_bib0106","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/210529","article-title":"A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease","volume":"2012","author":"Stan","year":"2012","journal-title":"J Thyroid Res"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0107","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijcard.2012.02.015","article-title":"Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease\u2013a cohort study","volume":"167","author":"Stan","year":"2013","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0108","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0735-1097(98)00495-1","article-title":"Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications","volume":"32","author":"Credner","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0109","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.4158\/EP13093.RA","article-title":"Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature","volume":"19","author":"Tomisti","year":"2013","journal-title":"Endocr Pract"},{"issue":"11 Pt 1","key":"10.1016\/j.tcm.2018.09.005_bib0110","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1540-8159.1996.tb03179.x","article-title":"Amiodarone induced hyperthyroidism: a case series and brief review of literature","volume":"19","author":"Harjai","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0111","first-page":"1062","article-title":"Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management","volume":"102","author":"Brennan","year":"1987","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0112","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2362.1984.tb01212.x","article-title":"Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases","volume":"14","author":"Leger","year":"1984","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0113","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1476-5381.1970.tb09891.x","article-title":"The effect of amiodarone, a new anti-anginal drug, on cardiac muscle","volume":"39","author":"Singh","year":"1970","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0114","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2265.1985.tb03238.x","article-title":"Amiodarone and thyroid hormone action","volume":"22","author":"Franklyn","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0002-8703(81)90140-X","article-title":"Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone","volume":"101","author":"Marcus","year":"1981","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.tcm.2018.09.005_bib0116","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study","volume":"81","author":"Bartalena","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0117","first-page":"423","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis","volume":"78","author":"Bartalena","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/jcem-14-1-70","article-title":"Preliminary experience in the treatment of hyperthyroidism with potassium perchlorate","volume":"14","author":"Godley","year":"1954","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0119","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1210\/jc.2004-1821","article-title":"The effect of perchlorate, thiocyanate, and nitrate on thyroid function in workers exposed to perchlorate long-term","volume":"90","author":"Braverman","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03348098","article-title":"Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole","volume":"9","author":"Martino","year":"1986","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.tcm.2018.09.005_bib0121","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/009127006200200603","article-title":"The relative toxicity of antithyroid drugs","volume":"2","author":"Trotter","year":"1962","journal-title":"J New Drugs"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0122","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/jcem-58-1-62","article-title":"Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs","volume":"58","author":"Wenzel","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0123","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF03348187","article-title":"Failure to control hyperthyroidism with a thionamide after KClO4 withdrawal in a patient with amiodarone associated thyrotoxicosis","volume":"10","author":"De Weweire","year":"1987","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.tcm.2018.09.005_bib0124","unstructured":"Ross DS. Pharmacology and toxicity of thionamides. Available at: http:\/\/www.uptodate.com\/contents\/pharmacology-and-toxicity-of-thionamides. Last accessed 8\/13\/18."},{"issue":"9","key":"10.1016\/j.tcm.2018.09.005_bib0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0126","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1210\/jc.2011-2221","article-title":"Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease","volume":"97","author":"Watanabe","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.tcm.2018.09.005_bib0127","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/thy.2008.0097","article-title":"Antithyroid drug-induced aplastic anemia","volume":"18","author":"Thomas","year":"2008","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0128","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(97)00047-8","article-title":"Lithium treatment in amiodarone-induced thyrotoxicosis","volume":"102","author":"Dickstein","year":"1997","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-4165(78)90242-8","article-title":"Studies on the mechanism of inhibition of thyroid function by lithium","volume":"542","author":"Bagchi","year":"1978","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0130","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1172\/JCI106352","article-title":"Antithyroid effects of lithium","volume":"49","author":"Berens","year":"1970","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0131","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/jcem-32-5-647","article-title":"Effect of lithium on thyroid function","volume":"32","author":"Burrow","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0132","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jcem-35-6-905","article-title":"The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients","volume":"35","author":"Spaulding","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tcm.2018.09.005_bib0133","unstructured":"Ross DS. Beta blockers in the treatment of hyperthyroidism. Available at: http:\/\/www.uptodate.com\/contents\/beta-blockers-in-the-treatment-of-hyperthyroidism Last accessed 8\/13\/18."},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0134","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ecl.2006.09.008","article-title":"Thyrotoxicosis and thyroid storm","volume":"35","author":"Nayak","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0885066613498053","article-title":"Thyroid storm: an updated review","volume":"30","author":"Chiha","year":"2015","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.tcm.2018.09.005_bib0136","first-page":"747","article-title":"Graves' ophthalmopathy: current concepts regarding pathogenesis and management","volume":"14","author":"Burch","year":"1993","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.tcm.2018.09.005_bib0137","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1172\/JCI106225","article-title":"Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis","volume":"49","author":"Wartofsky","year":"1970","journal-title":"J Clin Invest"},{"issue":"1-3","key":"10.1016\/j.tcm.2018.09.005_bib0138","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12020-008-9107-5","article-title":"Low doses of cholestyramine in the treatment of hyperthyroidism","volume":"34","author":"Kaykhaei","year":"2008","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.tcm.2018.09.005_bib0139","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.2005.02249.x","article-title":"The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism","volume":"62","author":"Tsai","year":"2005","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.tcm.2018.09.005_bib0140","first-page":"3191","article-title":"Treatment of hyperthyroidism with a combination of methimazole and cholestyramine","volume":"81","author":"Mercado","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tcm.2018.09.005_bib0141","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006696","article-title":"Surviving the storm: two cases of thyroid storm successfully treated with plasmapheresis","volume":"2012","author":"Carhill","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0142","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.amjcard.2016.01.003","article-title":"Amiodarone-induced thyrotoxicosis recurrence after amiodarone reintroduction","volume":"117","author":"Maqdasy","year":"2016","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0143","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1210\/jcem-70-6-1518","article-title":"Current trends in the management of Graves' disease","volume":"70","author":"Solomon","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tcm.2018.09.005_bib0144","doi-asserted-by":"crossref","unstructured":"Meurisse M, Hamoir E, D'Silva M, Joris J, Hennen G. Amiodarone-induced thyrotoxicosis: is there a place for surgery? World journal of surgery. 1993; 17(5): 622\u20136; discussion 7.","DOI":"10.1007\/BF01659125"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0145","first-page":"1114","article-title":"Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy","volume":"114","author":"Mulligan","year":"1993","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0146","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.anorl.2014.04.005","article-title":"Surgical management of hyperthyroidism","volume":"132","author":"Querat","year":"2015","journal-title":"Eur Ann Otorhinolaryngol, Head Neck Dis"},{"issue":"10","key":"10.1016\/j.tcm.2018.09.005_bib0147","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/105072503322511337","article-title":"Is there a place for thyroidectomy in older patients with thyrotoxic storm and cardiorespiratory failure?","volume":"13","author":"Scholz","year":"2003","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.tcm.2018.09.005_bib0148","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1990.03440110092034","article-title":"Thyroidectomy for amiodarone-induced thyrotoxicosis","volume":"263","author":"Farwell","year":"1990","journal-title":"JAMA"},{"issue":"4 Pt 2","key":"10.1016\/j.tcm.2018.09.005_bib0149","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/0002-8703(83)90017-0","article-title":"Drug interactions with amiodarone","volume":"106","author":"Marcus","year":"1983","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.tcm.2018.09.005_bib0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.109.858027","article-title":"Dronedarone","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.tcm.2018.09.005_bib0151","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCEP.111.963447","article-title":"Acute liver failure associated with dronedarone","volume":"4","author":"Joghetaei","year":"2011","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"1607","key":"10.1016\/j.tcm.2018.09.005_bib0152","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","article-title":"Endocannabinoids in nervous system health and disease: the big picture in a nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos Trans R Soc Lond Ser B"},{"key":"10.1016\/j.tcm.2018.09.005_bib0153","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0154","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1164\/ajrccm.186.2.201","article-title":"A 73-year-old man with interstitial lung disease due to dronedarone","volume":"186","author":"Hernandez Voth","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.tcm.2018.09.005_bib0155","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2018.09.005_bib0156","doi-asserted-by":"crossref","unstructured":"Exposito V, Rodriguez-Entem F, Gonzalez-Enriquez S, Olalla JJ. Dronedarone for recurrent ventricular tachycardia: a real alternative? Indian Pacing Electrophysiol J. 2012; 12(2): 73\u20136.","DOI":"10.1016\/S0972-6292(16)30483-1"},{"issue":"2","key":"10.1016\/j.tcm.2018.09.005_bib0157","first-page":"201","article-title":"Suppression of ventricular tachycardia with dronedarone: a case report","volume":"22","author":"Shaaraoui","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"25","key":"10.1016\/j.tcm.2018.09.005_bib0158","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.tcm.2018.09.005_bib0159","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ahj.2008.06.010","article-title":"Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"},{"issue":"24","key":"10.1016\/j.tcm.2018.09.005_bib0160","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2018.09.005_bib0161","first-page":"e506","article-title":"2015 ACC\/AHA\/ HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.09.005_bib0162","unstructured":"Giardina EG, Zimetbaum PJ. Amiodarone: monitoring and management of side effects. Available at: https:\/\/www.uptodate.com\/contents\/amiodarone-monitoring-and-management-of-sideeffects?search=amiodarone%20toxicity&source=search_result&selectedTitle=1\u223c48&usage_type=default&display_rank=1."},{"issue":"Aug (2)","key":"10.1016\/j.tcm.2018.09.005_bib0163","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0003-4975(03)00509-5","article-title":"Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients","volume":"76","author":"Cheung","year":"2003","journal-title":"Ann Thorac Surg"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173818301956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173818301956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:58:39Z","timestamp":1760936319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173818301956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":163,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1050173818301956"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2018.09.005","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiodarone and thyroid physiology, pathophysiology, diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}